1. Home
  2. Browse
  3. Gastroenterology
  4. Liver Disease
  5. Monitoring

Monitoring

16 - 29 of 29 Results
Sort Results:
Article: controversy about what works to prevent contrast-induced nephropathy December 2013
Article: myths perpetuated about meds in chronic liver disease October 2013
PL Voices: Myths About Medication Use in Chronic Liver Disease October 2013
Article: two new cholesterol-lowering drugs, Kynamro (kye-NAM-roe, mipomersen) and Juxtapid (JUKS-tuh-pid, lomitapide) April 2013
Article: Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease April 2013
Article: Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS) November 2012
Article: fewer liver enzyme tests to order for statin patients May 2012
PL Voices: When to Monitor Liver Enzymes for Patients taking Statins May 2012
Article: whether it's okay for patients with elevated liver enzymes to take a statin January 2011
Commentary: Statins and the Liver January 2011
Article: what lab tests are needed for certain drugs July 2010
Article: Xifaxan (rifaximin) now comes in a 550 mg tablet to prevent hepatic encephalopathy due to chronic liver disease June 2010
Commentary: Rifaximin (Xifaxan) for Hepatic Encephalopathy June 2010
Article: risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID December 2006